A randomized double-blind controlled study protocol on the efficacy and safety of Sangdantongluo granule in the treatment of post-stroke spasticity

INTRODUCTION: Stroke is the first leading cause of mortality and disability worldwide, and post-stroke spasticity (PSS) is the common complication of stroke. Sangdantongluo Granule (Z20210481000), a modern patent Chinese medicine, is widely used in clinical practice to treat PSS. Whereas, there is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Le, Xie, Yao, Mao, Guo, Jiang, Junlin, Yao, Ting, Fang, Rui, Yue, Zenghui, Li, Yingchen, Wu, Dahua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421167/
https://www.ncbi.nlm.nih.gov/pubmed/36046209
http://dx.doi.org/10.1016/j.conctc.2022.100975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421167/
https://www.ncbi.nlm.nih.gov/pubmed/36046209
http://dx.doi.org/10.1016/j.conctc.2022.100975

Ejemplares similares